InsiderTrades.com logo

NTLA Insider Trading

Insider Ownership Percentage: 3.50%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $650,158.45

Intellia Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Intellia Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Intellia Therapeutics Share Price & Price History

Current Price: $11.75
Price Change: ▼ Price Decrease of -0.41 (-3.37%)
As of 09/25/2026 04:00 PM ET

This chart shows the closing price history over time for NTLA up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Intellia Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/2/2026J Dulac IIIEVPSell4,677$18.00$84,186.00156,286View SEC Filing Icon  
7/1/2026Michael P DubeCAOSell2,641$16.78$44,315.9866,886View SEC Filing Icon  
1/5/2026Birgit C SchultesEVPSell8,508$9.21$78,358.6898,533View SEC Filing Icon  
1/5/2026James BastaEVPSell10,397$9.21$95,756.37101,528View SEC Filing Icon  
1/5/2026John M LeonardCEOSell34,146$9.21$314,484.661,013,339View SEC Filing Icon  
10/1/2025Birgit C SchultesEVPSell31$17.38$538.78105,184View SEC Filing Icon  
10/1/2025Michael P DubeCAOSell1,871$17.38$32,517.9855,266View SEC Filing Icon  
8/20/2025William J. ChaseDirectorBuy100,000$10.03$1,003,000.00134,693View SEC Filing Icon  
7/23/2025J Dulac IIIEVPSell7,462$14.02$104,617.24106,062View SEC Filing Icon  
7/2/2025Michael P DubeCAOSell2,503$9.95$24,904.8557,137View SEC Filing Icon  
7/1/2025Eliana ClarkEVPSell1,022$9.82$10,036.0495,369View SEC Filing Icon  
7/1/2025Jesse GoodmanDirectorSell1,547$9.23$14,278.8124,359View SEC Filing Icon  
4/29/2025Muna BhanjiDirectorSell265$8.50$2,252.5019,203View SEC Filing Icon  
1/29/2025Muna BhanjiDirectorSell265$9.97$2,642.0519,468View SEC Filing Icon  
1/3/2025John M LeonardCEOSell26,807$12.18$326,509.26941,115View SEC Filing Icon  
1/3/2025Michael P DubeCAOSell1,372$12.18$16,710.9645,640View SEC Filing Icon  
1/2/2025Eliana ClarkEVPSell556$12.03$6,688.6871,470View SEC Filing Icon  
10/2/2024Michael P DubeCAOSell2,012$19.01$38,248.1247,012View SEC Filing Icon  
7/1/2024Eliana ClarkEVPSell405$22.93$9,286.6571,470View SEC Filing Icon  
3/4/2024James BastaEVPSell2,297$32.99$75,778.0381,571View SEC Filing Icon  
1/8/2024Laura Sepp-LorenzinoEVPSell2,275$28.87$65,679.2543,927View SEC Filing Icon  
1/3/2024David LebwohlEVPSell5,843$29.46$172,134.7854,372View SEC Filing Icon  
1/3/2024Glenn GoddardCFOSell5,365$29.46$158,052.9040,585View SEC Filing Icon  
1/3/2024John M LeonardCEOSell19,223$29.46$566,309.58846,486View SEC Filing Icon  
10/31/2023Muna BhanjiDirectorSell265$23.90$6,333.5011,996View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Intellia Therapeutics (NASDAQ:NTLA)

88.77% of Intellia Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at NTLA by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Intellia Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
9/9/2026Opaleye Management Inc.250,000$4.23M0.4%+2.0%0.178%Search for SEC Filing on Google Icon
9/9/2026Engineers Gate Manager LP84,728$1.43M0.0%-29.6%0.060%Search for SEC Filing on Google Icon
9/9/2026Integrated Wealth Concepts LLC1,981$34K0.0%N/A0.001%Search for SEC Filing on Google Icon
9/8/2026Arizona State Retirement System35,356$0.60M0.0%+17.0%0.025%Search for SEC Filing on Google Icon
9/8/2026Nykredit A S1,940$33K0.0%N/A0.001%Search for SEC Filing on Google Icon
8/26/2026Wellington Grp LLC67,688$1.15M0.3%+46.2%0.048%Search for SEC Filing on Google Icon
8/26/2026HighTower Advisors LLC49,129$0.83M0.0%+338.7%0.035%Search for SEC Filing on Google Icon
8/25/2026VIRGINIA RETIREMENT SYSTEMS ET Al20,242$0.34M0.0%N/A0.014%Search for SEC Filing on Google Icon
8/21/2026AXQ Capital LP32,801$0.56M0.1%N/A0.023%Search for SEC Filing on Google Icon
8/21/2026Nykredit A S1,940$33K0.0%N/A0.001%Search for SEC Filing on Google Icon
8/20/2026Headlands Technologies LLC94,250$1.60M0.2%N/A0.067%Search for SEC Filing on Google Icon
8/20/2026Susquehanna Fundamental Investments LLC37,663$0.64M0.0%N/A0.027%Search for SEC Filing on Google Icon
8/20/2026Sigma Planning Corp10,141$0.17M0.0%N/A0.007%Search for SEC Filing on Google Icon
8/20/2026Two Sigma Securities LLC19,395$0.33M0.0%N/A0.014%Search for SEC Filing on Google Icon
8/20/2026Benjamin Edwards Inc.80,881$1.37M0.0%-2.0%0.058%Search for SEC Filing on Google Icon
8/19/2026UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC312,809$5.29M0.0%+10.2%0.223%Search for SEC Filing on Google Icon
8/19/2026Hsbc Holdings PLC59,687$1M0.0%+23.7%0.043%Search for SEC Filing on Google Icon
8/19/2026Wellington Management Group LLP43,484$0.74M0.0%+2.7%0.031%Search for SEC Filing on Google Icon
8/18/2026Empowered Funds LLC13,383$0.23M0.0%N/A0.010%Search for SEC Filing on Google Icon
8/18/2026Dearborn Partners LLC15,825$0.27M0.0%N/A0.011%Search for SEC Filing on Google Icon
8/18/2026Public Employees Retirement System of Ohio88,257$1.49M0.0%N/A0.063%Search for SEC Filing on Google Icon
8/17/2026Bank of America Corp DE976,216$16.52M0.0%N/A0.697%Search for SEC Filing on Google Icon
8/15/2026Freestone Grove Partners LP1,958$33K0.0%N/A0.001%Search for SEC Filing on Google Icon
8/15/2026Gallagher Fiduciary Advisors LLC11,683$0.20M0.0%N/A0.008%Search for SEC Filing on Google Icon
8/15/2026Jupiter Topco LLC47,957$0.81M0.0%N/A0.034%Search for SEC Filing on Google Icon
8/14/2026Hsbc Holdings PLC59,687$1M0.0%N/A0.043%Search for SEC Filing on Google Icon
8/14/2026PDT Partners LLC37,076$0.63M0.0%N/A0.026%Search for SEC Filing on Google Icon
8/14/2026Canada Pension Plan Investment Board26,900$0.46M0.0%N/A0.019%Search for SEC Filing on Google Icon
8/14/2026Legal & General Group Plc114,006$1.93M0.0%N/A0.081%Search for SEC Filing on Google Icon
8/14/2026The Manufacturers Life Insurance Company57,036$0.97M0.0%N/A0.041%Search for SEC Filing on Google Icon
8/14/2026Dearborn Partners LLC14,994$0.19M0.0%N/A0.011%Search for SEC Filing on Google Icon
8/14/2026Algert Global LLC49,200$0.83M0.0%+124.5%0.035%Search for SEC Filing on Google Icon
8/13/2026Connor Clark & Lunn Investment Management Ltd.898,963$15.21M0.0%N/A0.642%Search for SEC Filing on Google Icon
8/12/2026Elevation Point Wealth Partners LLC188,207$3.18M0.1%N/A0.135%Search for SEC Filing on Google Icon
8/12/2026Northwestern Mutual Wealth Management Co.10,583$0.18M0.0%N/A0.008%Search for SEC Filing on Google Icon
8/12/2026Quantbot Technologies LP30,260$0.51M0.0%N/A0.022%Search for SEC Filing on Google Icon
8/12/2026Orchard Capital Management LLC79,503$1.35M1.3%N/A0.057%Search for SEC Filing on Google Icon
8/12/2026Ieq Capital LLC49,375$0.84M0.0%N/A0.035%Search for SEC Filing on Google Icon
8/11/2026Green Alpha Advisors LLC13,886$0.24M0.2%N/A0.010%Search for SEC Filing on Google Icon
8/11/2026Allworth Financial LP3,241$55K0.0%N/A0.002%Search for SEC Filing on Google Icon
8/11/2026E Fund Management Co. Ltd.22,501$0.38M0.0%N/A0.016%Search for SEC Filing on Google Icon
8/8/2026Wealthfront Advisers LLC18,196$0.31M0.0%N/A0.013%Search for SEC Filing on Google Icon
8/7/2026Grandfield & Dodd LLC49,680$0.84M0.0%N/A0.036%Search for SEC Filing on Google Icon
8/7/2026BlackRock Inc.15,409,023$260.72M0.0%N/A11.029%Search for SEC Filing on Google Icon
8/7/2026Deutsche Bank AG210,550$3.56M0.0%N/A0.151%Search for SEC Filing on Google Icon
8/7/2026Mitsubishi UFJ Asset Management Co. Ltd.21,435$0.36M0.0%N/A0.015%Search for SEC Filing on Google Icon
8/6/2026Bank of New York Mellon Corp410,654$6.95M0.0%N/A0.294%Search for SEC Filing on Google Icon
8/6/2026State of Wyoming3,042$51K0.0%N/A0.002%Search for SEC Filing on Google Icon
8/6/2026GSA Capital Partners LLP13,823$0.23M0.0%N/A0.010%Search for SEC Filing on Google Icon
7/10/2026Wasatch Advisors LP127,649$2.16M0.0%-51.3%0.091%Search for SEC Filing on Google Icon
7/9/2026Hennion & Walsh Asset Management Inc.220,523$3.73M0.1%+38.0%0.158%Search for SEC Filing on Google Icon
6/4/2026Seven Fleet Capital Management LP31,500$0.40M0.1%N/A0.023%Search for SEC Filing on Google Icon
5/28/2026Avidity Partners Management LP75,000$0.96M0.2%N/A0.054%Search for SEC Filing on Google Icon
5/22/2026Wellington Grp LLC46,297$0.59M0.2%+50.9%0.033%Search for SEC Filing on Google Icon
5/19/2026Bank of America Corp DE1,381,703$17.71M0.0%+11.2%0.989%Search for SEC Filing on Google Icon
5/18/2026ADAR1 Capital Management LLC19,517$0.25M0.0%N/A0.014%Search for SEC Filing on Google Icon
5/18/2026California State Teachers Retirement System138,259$1.77M0.0%+39.6%0.099%Search for SEC Filing on Google Icon
5/18/2026Royal Bank of Canada465,499$5.97M0.0%+1,082.1%0.333%Search for SEC Filing on Google Icon
5/16/2026Quantinno Capital Management LP39,709$0.51M0.0%+18.7%0.028%Search for SEC Filing on Google Icon
5/16/2026Lazard Asset Management LLC93,620$1.20M0.0%-5.2%0.067%Search for SEC Filing on Google Icon
5/14/2026Arrowstreet Capital Limited Partnership1,397,243$17.91M0.0%N/A1.000%Search for SEC Filing on Google Icon
5/14/2026Sei Investments Co.20,093$0.26M0.0%+13.0%0.014%Search for SEC Filing on Google Icon
5/13/2026Cetera Investment Advisers53,793$0.69M0.0%+6.3%0.039%Search for SEC Filing on Google Icon
5/12/2026Himension Capital Singapore PTE. LTD.429,540$5.51M0.4%-25.8%0.357%Search for SEC Filing on Google Icon
5/8/2026PNC Financial Services Group Inc.3,552$46K0.0%+36.4%0.003%Search for SEC Filing on Google Icon
5/8/2026Amova Asset Management Americas Inc.1,973,061$25.28M0.4%-10.0%1.638%Search for SEC Filing on Google Icon
5/7/2026Hollencrest Capital Management3,828$49K0.0%N/A0.003%Search for SEC Filing on Google Icon
5/7/2026Dimensional Fund Advisors LP2,318,110$29.71M0.0%+20.0%1.924%Search for SEC Filing on Google Icon
5/7/2026KBC Group NV3,928$50K0.0%-35.5%0.003%Search for SEC Filing on Google Icon
5/7/2026Swiss National Bank217,800$2.79M0.0%+8.4%0.181%Search for SEC Filing on Google Icon
5/6/2026Allspring Global Investments Holdings LLC19,240$0.26M0.0%+11.5%0.016%Search for SEC Filing on Google Icon
5/6/2026Independent Financial Group LLC15,302$0.20M0.0%N/A0.013%Search for SEC Filing on Google Icon
5/5/2026Wealthfront Advisers LLC14,450$0.19M0.0%+7.6%0.012%Search for SEC Filing on Google Icon
5/5/2026D.A. Davidson & CO.93,260$1.20M0.0%+11.0%0.077%Search for SEC Filing on Google Icon
5/5/2026Bank of New York Mellon Corp328,000$4.21M0.0%+4.4%0.278%Search for SEC Filing on Google Icon
5/4/2026Canal Insurance CO230,000$2.95M0.6%+130.0%0.195%Search for SEC Filing on Google Icon
5/1/2026Fifth Third Bancorp2,953$38K0.0%N/A0.002%Search for SEC Filing on Google Icon
4/30/2026Hsbc Holdings PLC48,259$0.61M0.0%-5.3%0.041%Search for SEC Filing on Google Icon
4/30/2026Sumitomo Mitsui Trust Group Inc.1,973,061$25.30M0.0%-10.0%1.670%Search for SEC Filing on Google Icon
4/29/2026Axxcess Wealth Management LLC22,707$0.29M0.0%+6.1%0.019%Search for SEC Filing on Google Icon
4/27/2026Y Intercept Hong Kong Ltd141,081$1.81M0.0%N/A0.119%Search for SEC Filing on Google Icon
4/27/2026Leonteq Securities AG8,666$0.11M0.0%-84.7%0.007%Search for SEC Filing on Google Icon
4/27/2026Elevation Point Wealth Partners LLC167,807$2.15M0.0%+93.8%0.142%Search for SEC Filing on Google Icon
4/22/2026Pictet Asset Management Holding SA16,933$0.22M0.0%+47.2%0.014%Search for SEC Filing on Google Icon
4/22/2026Sterling Capital Management LLC3,679$47K0.0%-39.3%0.003%Search for SEC Filing on Google Icon
4/22/2026Lewis Asset Management LLC19,770$0.25M0.1%+38.5%0.017%Search for SEC Filing on Google Icon
4/21/2026Wasatch Advisors LP261,864$3.36M0.0%-16.5%0.222%Search for SEC Filing on Google Icon
4/16/2026SG Americas Securities LLC89,688$1.15M0.0%+22.6%0.076%Search for SEC Filing on Google Icon
3/20/2026Hsbc Holdings PLC50,946$0.46M0.0%-6.6%0.043%Search for SEC Filing on Google Icon
3/17/2026Rockefeller Capital Management L.P.140,218$1.26M0.0%+1.7%0.119%Search for SEC Filing on Google Icon
2/23/2026Virtu Financial LLC27,260$0.25M0.0%N/A0.024%Search for SEC Filing on Google Icon
2/19/2026Invesco Ltd.433,290$3.90M0.0%+5.8%0.374%Search for SEC Filing on Google Icon
2/19/2026Axxcess Wealth Management LLC21,399$0.19M0.0%+20.1%0.018%Search for SEC Filing on Google Icon
2/18/2026Mercer Global Advisors Inc. ADV10,029$90K0.0%N/A0.009%Search for SEC Filing on Google Icon
2/18/2026XTX Topco Ltd44,763$0.40M0.0%N/A0.039%Search for SEC Filing on Google Icon
2/18/2026VARCOV Co.29,109$0.26M0.1%N/A0.025%Search for SEC Filing on Google Icon
2/18/2026Voloridge Investment Management LLC1,737,450$15.62M0.1%+7.9%1.500%Search for SEC Filing on Google Icon
2/18/2026Virtus Investment Advisers LLC29,493$0.27M0.1%+116.4%0.025%Search for SEC Filing on Google Icon
2/18/2026SummitTX Capital L.P.17,287$0.16M0.0%N/A0.015%Search for SEC Filing on Google Icon
2/18/2026Twinbeech Capital LP15,289$0.14M0.0%N/A0.013%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Intellia Therapeutics logo
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of curative therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; NTLA-2002 for the treatment of hereditary angioedema; and NTLA-3001 for alpha-1 antitrypsin deficiency associated lung disease. It also focusses on programs comprising hemophilia A and hemophilia B; and research of proprietary programs focused on developing engineered cell therapies to treat various cancers and autoimmune diseases. In addition, the company offers tools comprising of Clustered, Regularly Interspaced Short Palindromic Repeats/CRISPR associated 9 (CRISPR/Cas9) system. It has license and collaboration agreement with Regeneron Pharmaceuticals, Inc. to co-develop potential products for the treatment of hemophilia A and hemophilia B; AvenCell Therapeutics, Inc. to develop allogeneic universal CAR-T cell therapies, and co-develop and co-commercialize allogeneic universal CAR-T cell products for an immuno-oncology indication; SparingVision SAS to develop novel genomic medicines utilizing CRISPR/Cas9 technology for the treatment of ocular diseases; Kyverna Therapeutics, Inc. for the development of an allogeneic CD19 CAR-T cell therapy for the treatment of a variety of B cell-mediated autoimmune diseases; and ONK Therapeutics, Ltd. for the development of engineered NK cell therapies to cure patients with cancer. Intellia Therapeutics, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.
Read More on Intellia Therapeutics

Today's Range

Now: $11.75
Low: $11.67
High: $12.33

50 Day Range

MA: $11.97
Low: $10.67
High: $13.51

52 Week Range

Now: $11.75
Low: $7.95
High: $28.25

Volume

2,975,682 shs

Average Volume

5,109,605 shs

Market Capitalization

$1.65 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.82

Who are the company insiders with the largest holdings of Intellia Therapeutics?

Intellia Therapeutics' top insider investors include:
  1. John M Leonard (CEO)
  2. John M Leonard (CEO)
  3. Nessan Bermingham (CEO)
  4. Edward J Dulac III (EVP)
  5. Jose E Rivera (EVP)
  6. William J Chase (Director)
  7. Birgit C Schultes (EVP)
  8. James Basta (EVP)
  9. Eliana Clark (EVP)
  10. Michael P Dube (CAO)
Learn More about top insider investors at Intellia Therapeutics.

Who are the major institutional investors of Intellia Therapeutics?

Intellia Therapeutics' top institutional shareholders include:
  1. BlackRock Inc. — 11.03%
  2. Bank of America Corp DE — 0.70%
  3. Connor Clark & Lunn Investment Management Ltd. — 0.64%
  4. Bank of New York Mellon Corp — 0.29%
  5. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC — 0.22%
  6. Opaleye Management Inc. — 0.18%
Learn More about top institutional investors of Intellia Therapeutics stock.

Which institutional investors are selling Intellia Therapeutics stock?

Within the previous quarter, NTLA stock was sold by these institutional investors:
  1. Wasatch Advisors LP
  2. Engineers Gate Manager LP
  3. Benjamin Edwards Inc.
In the previous year, company insiders that have sold Intellia Therapeutics company stock include:
  1. John M Leonard (CEO)
  2. Edward J Dulac III (EVP)
  3. Birgit C Schultes (EVP)
  4. James Basta (EVP)
  5. Michael P Dube (CAO)
Learn More investors selling Intellia Therapeutics stock.

Which institutional investors are buying Intellia Therapeutics stock?

Within the last quarter, NTLA stock was purchased by institutional investors including:
  1. BlackRock Inc.
  2. Bank of America Corp DE
  3. Connor Clark & Lunn Investment Management Ltd.
  4. Bank of New York Mellon Corp
  5. Deutsche Bank AG
  6. Elevation Point Wealth Partners LLC
  7. Legal & General Group Plc
  8. Headlands Technologies LLC

Intellia Therapeutics Active Insiders

John M. Leonard
John M. Leonard (Age 68)
CEO
Andrew Schiermeier
Andrew Schiermeier
COO
Glenn Goddard
Glenn Goddard (Age 55)
CFO
Michael P Dube
Michael P Dube (Age 48)
CAO
1 recent trades
Jean Francois Formela
Jean Francois Formela
Director
John F Crowley
John F Crowley
Director
Caroline Dorsa
Caroline Dorsa
Director
Jesse Goodman
Jesse Goodman
Director
William J Chase
Director
James Basta
James Basta
EVP, General Counsel and Corporate Secretary
David Lebwohl
David Lebwohl (Age 71)
EVP
Laura Sepp-Lorenzino
Laura Sepp-Lorenzino (Age 65)
EVP
Jose E Rivera
Jose E Rivera
EVP
Eliana Clark
Eliana Clark
EVP
Birgit C Schultes
Birgit C Schultes
EVP
Edward J Dulac III
Edward J Dulac III (Age 50)
EVP
1 recent trades